Acelyrin Inc (SLRN)
4.79
+0.18
(+3.79%)
USD |
NASDAQ |
May 08, 11:11
Acelyrin Price: 4.79 for May 8, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 07, 2024 | 4.36 | 4.77 | 4.32 | 4.615 | 1.038M |
| May 06, 2024 | 4.34 | 4.49 | 4.34 | 4.37 | 1.091M |
| May 03, 2024 | 4.30 | 4.47 | 4.265 | 4.35 | 946417.0 |
| May 02, 2024 | 4.34 | 4.37 | 4.22 | 4.25 | 943448.0 |
| May 01, 2024 | 4.19 | 4.38 | 4.19 | 4.25 | 1.143M |
| Apr 30, 2024 | 4.20 | 4.30 | 4.14 | 4.18 | 891946.0 |
| Apr 29, 2024 | 4.29 | 4.45 | 4.22 | 4.24 | 913736.0 |
| Apr 26, 2024 | 4.25 | 4.34 | 4.18 | 4.24 | 657192.0 |
| Apr 25, 2024 | 4.51 | 4.65 | 4.22 | 4.24 | 723193.0 |
| Apr 24, 2024 | 4.61 | 4.78 | 4.53 | 4.57 | 534843.0 |
| Apr 23, 2024 | 4.83 | 4.960 | 4.59 | 4.60 | 2.028M |
| Apr 22, 2024 | 5.10 | 5.134 | 4.79 | 4.82 | 1.033M |
| Apr 19, 2024 | 4.88 | 5.175 | 4.74 | 5.01 | 2.370M |
| Apr 18, 2024 | 5.00 | 5.10 | 4.76 | 4.88 | 1.210M |
| Apr 17, 2024 | 5.20 | 5.35 | 4.98 | 5.02 | 599571.0 |
| Apr 16, 2024 | 5.52 | 5.52 | 5.14 | 5.14 | 741171.0 |
| Apr 15, 2024 | 5.32 | 5.56 | 5.20 | 5.52 | 951665.0 |
| Apr 12, 2024 | 5.71 | 5.74 | 5.34 | 5.37 | 489507.0 |
| Apr 11, 2024 | 5.76 | 5.83 | 5.53 | 5.76 | 466165.0 |
| Apr 10, 2024 | 5.81 | 5.83 | 5.61 | 5.70 | 783664.0 |
| Apr 09, 2024 | 6.06 | 6.27 | 5.93 | 5.95 | 534183.0 |
| Apr 08, 2024 | 6.05 | 6.16 | 5.920 | 6.05 | 788919.0 |
| Apr 05, 2024 | 6.34 | 6.34 | 6.04 | 6.07 | 1.718M |
| Apr 04, 2024 | 6.64 | 6.81 | 6.34 | 6.39 | 771137.0 |
| Apr 03, 2024 | 6.50 | 6.77 | 6.46 | 6.63 | 756026.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.18
Minimum
Apr 30 2024
28.82
Maximum
Aug 22 2023
12.92
Average
9.14
Median
Price Benchmarks
| Lexicon Pharmaceuticals Inc | 1.81 |
| Eagle Pharmaceuticals Inc | 4.90 |
| Avalo Therapeutics Inc | 11.60 |
| Design Therapeutics Inc | 5.035 |
| CEL-SCI Corp | 1.94 |
Price Related Metrics
| Price to Book Value | 0.7178 |
| Earnings Yield | -80.07% |
| Market Cap | 471.17M |